Detailed information for compound 1821215

Basic information

Technical information
  • TDR Targets ID: 1821215
  • Name: 5,5-bis[(4-dimethylaminophenyl)methyl]-1,3-di azinane-2,4,6-trione
  • MW: 394.467 | Formula: C22H26N4O3
  • H donors: 2 H acceptors: 3 LogP: 2.85 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CN(c1ccc(cc1)CC1(Cc2ccc(cc2)N(C)C)C(=O)NC(=O)NC1=O)C
  • InChi: 1S/C22H26N4O3/c1-25(2)17-9-5-15(6-10-17)13-22(19(27)23-21(29)24-20(22)28)14-16-7-11-18(12-8-16)26(3)4/h5-12H,13-14H2,1-4H3,(H2,23,24,27,28,29)
  • InChiKey: FIZNQJNNOYRRDE-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 5,5-bis[(4-dimethylaminophenyl)methyl]hexahydropyrimidine-2,4,6-trione
  • 5,5-bis(4-dimethylaminobenzyl)barbituric acid

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0054 0.0198 0.0198
Onchocerca volvulus Deterin homolog 0.0894 1 0.5
Onchocerca volvulus 0.0894 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0894 1 1
Entamoeba histolytica hypothetical protein 0.0039 0.0024 0.5
Schistosoma mansoni inhibitor of apoptosis protein 0.0894 1 1
Entamoeba histolytica hypothetical protein 0.0039 0.0024 0.5
Brugia malayi Calcitonin receptor-like protein seb-1 0.0054 0.0198 0.0198
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0054 0.0198 0.0198
Brugia malayi photoreceptor-specific nuclear receptor 0.0288 0.2929 0.2929
Loa Loa (eye worm) hypothetical protein 0.0894 1 1
Loa Loa (eye worm) hypothetical protein 0.0288 0.2929 0.2929
Echinococcus multilocularis baculoviral IAP repeat containing protein 0.0894 1 1
Schistosoma mansoni hypothetical protein 0.0894 1 1
Echinococcus granulosus baculoviral IAP repeat containing protein 0.0894 1 1
Brugia malayi hypothetical protein 0.0039 0.0024 0.0024
Brugia malayi Inhibitor of Apoptosis domain containing protein 0.0894 1 1
Loa Loa (eye worm) hypothetical protein 0.0054 0.0198 0.0198
Echinococcus granulosus inhibitor of apoptosis protein 0.0894 1 1
Schistosoma mansoni hypothetical protein 0.0039 0.0024 0.0024
Schistosoma mansoni inhibitor of apoptosis (iap) domain family member 0.0894 1 1
Entamoeba histolytica hypothetical protein 0.0039 0.0024 0.5
Schistosoma mansoni transcription factor LCR-F1 0.0039 0.0024 0.0024
Echinococcus multilocularis inhibitor of apoptosis protein 0.0894 1 1
Entamoeba histolytica hypothetical protein 0.0039 0.0024 0.5

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) Antifungal activity against Candida albicans ATCC 10231 at 125 ug/ml after 48 to 72 hrs by broth microdilution method ChEMBL. 24361188

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.